| Period Ending | Jan 26, 2013 | Oct 27, 2012 | Jul 28, 2012 | Apr 28, 2012 |
|---|
|
Total Revenue
|
2,919,881
|
2,827,210
|
2,791,224
|
3,153,175
| | Cost of Revenue | 1,813,803 | 1,813,801 | 1,789,236 | 2,137,753 | | |
Gross Profit
|
1,106,078
|
1,013,409
|
1,001,988
|
1,015,422
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 628,125 | 621,712 | 591,650 | 734,152 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
477,953
|
391,697
|
410,338
|
281,270
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (11,994) | 5,567 | 10,624 | 4,042 |
|
Earnings Before Interest And Taxes | 469,957 | 393,266 | 420,962 | 285,312 |
|
Interest Expense | 69,735 | 69,963 | 73,371 | 76,000 |
|
Income Before Tax | 400,222 | 323,303 | 347,591 | 209,312 |
|
Income Tax Expense | 77,333 | 31,037 | 61,587 | 51,631 |
|
Minority Interest | (3,268) | (2,144) | (6,651) | (2,232) |
|
|
|
Net Income From Continuing Ops | 322,889 | 292,266 | 286,004 | 157,681 | |
|
Non-recurring Events |
|
Discontinued Operations | (50,075) | (678) | (21,326) | 19,893 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
269,546
|
289,444
|
258,027
|
175,342
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
269,546
|
289,444
|
258,027
|
175,342
|
|
0.12%